These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3088041)
1. Localization of the binding site of tissue-type plasminogen activator to fibrin. Ichinose A; Takio K; Fujikawa K J Clin Invest; 1986 Jul; 78(1):163-9. PubMed ID: 3088041 [TBL] [Abstract][Full Text] [Related]
2. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin. Soeda S; Kakiki M; Shimeno H; Nagamatsu A Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775 [TBL] [Abstract][Full Text] [Related]
3. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. van Zonneveld AJ; Veerman H; Pannekoek H J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732 [TBL] [Abstract][Full Text] [Related]
4. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments. de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823 [TBL] [Abstract][Full Text] [Related]
5. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator. Bakker AH; van der Greef W; Rehberg EF; Marotti KR; Verheijen JH J Biol Chem; 1993 Sep; 268(25):18496-501. PubMed ID: 8395505 [TBL] [Abstract][Full Text] [Related]
6. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli. Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612 [TBL] [Abstract][Full Text] [Related]
7. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1. Kaneko M; Sakata Y; Matsuda M; Mimuro J J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812 [TBL] [Abstract][Full Text] [Related]
8. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains. Robbins KC; Boreisha IG Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104 [TBL] [Abstract][Full Text] [Related]
9. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis. Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688 [TBL] [Abstract][Full Text] [Related]
10. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain. Váli Z; Patthy L J Biol Chem; 1984 Nov; 259(22):13690-4. PubMed ID: 6094526 [TBL] [Abstract][Full Text] [Related]
11. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]
12. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen. Boutaud A; Castellino FJ Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311 [TBL] [Abstract][Full Text] [Related]
13. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4. Mulichak AM; Tulinsky A Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798 [TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of fibrin-binding affinity of fibrinolytic components by frontal affinity chromatography. Kazama M; Tahara C; Abe T; Kasai K Thromb Res Suppl; 1988; 8():81-90. PubMed ID: 3144771 [TBL] [Abstract][Full Text] [Related]
15. Interaction of plasminogen and fibrin in plasminogen activation. Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048 [TBL] [Abstract][Full Text] [Related]
16. Effects of monoclonal antibodies on tissue-type plasminogen activator (t-PA) binding to lysine, fibrin and heparin and on fibrin-mediated enhancement of one-chain t-PA amidolytic activity. Fischer B; Zacharias U; Will H Biol Chem Hoppe Seyler; 1991 Apr; 372(4):263-71. PubMed ID: 1905550 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli. Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003 [TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site. Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule. Urano T; Takada Y; Takada A Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067 [TBL] [Abstract][Full Text] [Related]
20. Functional effects of kringle 2 glycosylation in a hybrid plasminogen activator. Asselbergs FA; Bürgi R; van Oostrum J Blood Coagul Fibrinolysis; 1993 Feb; 4(1):27-33. PubMed ID: 8384498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]